Chemoinformaics analysis of 2-Butyl methyl trisulphide
Molecular Weight | 168.352 | nRot | 4 |
Heavy Atom Molecular Weight | 156.256 | nRig | 0 |
Exact Molecular Weight | 168.01 | nRing | 0 |
Solubility: LogS | -4.536 | nHRing | 0 |
Solubility: LogP | 2.625 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 25.0515 |
nHD | 0 | BPOL | 14.4985 |
QED | 0.59 |
Synth | 4.247 |
Natural Product Likeliness | 1.179 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.001 |
HIA | 0.006 |
CACO-2 | -4.361 |
MDCK | 0.0000184 |
BBB | 0.787 |
PPB | 0.532061 |
VDSS | 1.296 |
FU | 0.331541 |
CYP1A2-inh | 0.933 |
CYP1A2-sub | 0.928 |
CYP2c19-inh | 0.953 |
CYP2c19-sub | 0.909 |
CYP2c9-inh | 0.828 |
CYP2c9-sub | 0.704 |
CYP2d6-inh | 0.026 |
CYP2d6-sub | 0.681 |
CYP3a4-inh | 0.015 |
CYP3a4-sub | 0.292 |
CL | 11.986 |
T12 | 0.206 |
hERG | 0.072 |
Ames | 0.238 |
ROA | 0.961 |
SkinSen | 0.944 |
Carcinogencity | 0.378 |
EI | 0.993 |
Respiratory | 0.98 |
NR-Aromatase | 0.012 |
Antiviral | No |
Prediction | 0.955957 |